The genetic basis of hypertriglyceridaemic states.

logo

Topic: Primary cardiovascular prevention: interventions and outcomes
Organised by University Hospital, Umea / Course Director: Ulf Naeslund / Supported by an unrestricted educational grant from AstraZeneca

About the speaker

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
39 presentations
0 follower

4 more presentations in this session

Welcome and introduction - Triglycerides and cardiovascular risk.

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Pathophysiology of hypertriglyceridaemia: relationship with cardiovascular risk.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Thumbnail

Therapeutic options for hypertriglyceridaemia: the future.

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Discussion and closing remarks - Triglycerides and cardiovascular risk.

Speaker: Professor J. Chapman (Paris, FR)

Thumbnail

Access the full session

Triglycerides and cardiovascular risk: the importance of treating hypertriglyceridaemia

Speakers: Professor E. Stroes, Professor J. Chapman, Professor B. Nordestgaard, Professor J. Chapman, Professor J. Chapman
Thumbnail

About the event

Image

ESC CONGRESS 2014

30 August - 3 September 2014

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb